For Thomas Holbro, who heads the development of new drugs in the cardiorenal and metabolic space, testing a hypothesis is like suspense in a good movie, happening on the edge of knowledge and science. His vast team`s work is all about asking the right questions and doing what no one else has done before for patients.

By Jovana Rakovic

Published on 22/11/2023